Int Immunopharmacology 81 (2020) 106257
Related Links
https://www.sciencedirect.com/science/article/pii/S1567576919324749
main text
NecroX-5 alleviate lipopolysaccharide-induced acute respiratory distress syndrome by inhibiting TXNIP/NLRP3 and NF-κB
NecroX-5 alleviate lipopolysaccharide-induced acute respiratory distress syndrome by inhibiting TXNIP/NLRP3 and NF-κB